bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2020.07.02.184556

How far are we in the rapid prediction of drug resistance caused by kinase mutations?

Erguven, M.·Karakulak, T.·Diril, K.·Karaca, E.
View original source ↗Export metadata ↓

Abstract

Protein kinases regulate various cell signaling events in a diverse range of species through phosphorylation. The phosphorylation occurs upon transferring the terminal phosphate of an ATP molecule to a designated target residue. Due to the central role of protein kinases in proliferative pathways, point mutations occurring within or in the vicinity of ATP binding pocket can render the enzyme overactive, leading to cancer. Combatting such mutation-induced effects with the available drugs has been a challenge, since these mutations usually happen to be drug resistant. Therefore, the functional study of naturally and/or artificially occurring kinase mutations have been at the center of attention in diverse biology-related disciplines. Unfortunately, rapid experimental exploration of the impact of such mutations remains to be a challenge due to technical and economical limitations. Therefore, the availability of kinase-ligand binding affinity prediction tools is of great importance. Within this context, we have tested six state-of-the-art web-based affinity predictors (DSX-ONLINE, KDEEP, HADDOCK2.2, PDBePISA, Pose&Rank, and PRODIGY-LIG) in assessing the impact of kinase mutations with their ligand interactions. This assessment is performed on our structure-based protein kinase mutation benchmark, BINDKIN. BINDKIN contains 23 wild type-mutant pairs of kinase-small molecule complexes, together with their corresponding binding affinity data (in the form of IC50, Kd, and Ki). The web-server performances over BINDKIN show that the raw server predictions fail to produce good correlations with the experimental data. However, when we start looking in to the direction of change (whether a mutation improves/worsens the binding), we observe that over Ki data, DSX-ONLINE achieves a Pearsons R correlation coefficient of 0.97. When we used homology models instead of crystal structures, this correlation drops to 0.45. These results highlight that there is still room to improve the available web-based predictors to estimate the impact of protein kinase point mutations. We present our BINDKIN benchmark and all the related results online for the sake of aiding such improvement efforts. Our files can be reached at https://github.com/CSB-KaracaLab/BINDKIN

Source connections

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Erguven, M., Karakulak, T., Diril, K., Karaca, E.. 2020-07-02. How far are we in the rapid prediction of drug resistance caused by kinase mutations?. https://doi.org/10.1101/2020.07.02.184556

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

RoDPAA: A Robust Dissimilarity-Based Principal Angle Analysis Framework for Multi-View Microbiome Data Integration

Multiview microbiome studies profile the same participants across body sites or molecular layers, but integration is hampered by sparse, compositional data, modest sample sizes and methods that recognize only exact sharing. We present RoDPAA (Robust Dissimilarity-based Principal Angle Analysis), a framework that represents each view through any data-appropriate dissimilarity, such as Bray--Curtis, without log-ratio transformation or likelihood assumptions. RoDPAA aligns view-specific signal subspaces through principal angles, captures complete and partial sharing, and tests by permutation how many components are shared, using only eigendecomposition and little tuning. In Gaussian simulations, RoDPAA matched JIVE and MOFA given true ranks, ran faster and alone recovered the shared dimension in every replicate. In two inflammatory bowel disease (IBD) cohorts with sparse, zero-inflated data, Bray--Curtis-based RoDPAA recovered shared structure that was stable to prevalence filtering, whereas log-ratio-based alternatives were not. Its leading microbiome--metabolome factors, learned without disease labels, were the only ones associated with IBD.

bioinformatics↗
bioRxiv2026

Deducing splicing events from transcript sets with splicelogic

Long-read RNA sequencing captures a greater proportion of full-length transcripts, enabling more accurate isoform identification, discovery of novel isoforms, and more precise differential transcript usage analysis. However, comparing transcripts, whether between conditions or between sets such as novel and annotated isoforms, yields complex isoform changes that are hard to manipulate, summarize, and visualize. This is compounded by vertical integration of some tools, where downstream analysis depends on the specific output of a particular upstream tool. To address this gap, we have developed splicelogic, an R/Bioconductor package that makes transcript-set comparisons biologically interpretable by turning them into discrete splicing events, such as exon skipping, alternative splice sites, intron retention, and alternative transcription start and end sites. We designed splicelogic to integrate easily with existing RNA-seq workflows and tools. The splicelogic functions are modular, readable, and extensible, making it easy for users to adapt core logic to their own custom scientific questions or novel splicing definitions. By obtaining interpretable splicing events from transcript changes, splicelogic enables downstream analyses, including annotation of RNA-binding protein recognition sites, alongside summary statistics and visualization. The splicelogic package is publicly available and distributed through Bioconductor.

bioinformatics↗
bioRxiv2026

Contrastive Learning Improves Generalization on M2OR Olfactory Binding Dataset

Olfaction-based biosensors stand to have profound impacts in fields such as medical diagnostics, national security, and drug discovery. A promising mode of vapor phase biodetection mimics volatile organic compound-olfactory receptor (VOC-OR) interactions with target-specific protein or peptide probes; however, lack of experimental coverage remains a core bottleneck. Current computational approaches aim to improve prediction of VOC-OR binding to reduce experimental burden, and current machine learning approaches fail to demonstrate a level of generalization that addresses current engineering challenges. Here, using the Molecular to Olfactory Dataset (M2OR) and Insect Olfactory Binding Protein Database (iOBPdb) datasets, data partitioning methods and their performance are evaluated on a neural network and contrastive learning framework on such VOC-OR binding datasets, varying: model training, architecture, and structure of the input data distribution. It was found that holding out certain chemical or proteomic motifs from the training data diminished model performance with a two layer neural network model. The model was able to generalize to state of the art performance (0.88 AUCROC) on every data split by applying a contrastive learning objective defined by shared molecular constituents and a stochastic sampler. This suggests the contrastive objective provides a strong inductive bias for neural networks to predict novel VOC-OR pairs. These findings highlight that model performance on pairwise biological interaction datasets can be inflated through identity leakage from constituent overlap, and emphasize the need for more robust evaluation protocols. Furthermore, we show contrastive regularization mitigates dataset degeneracy through enforcement of compatibility in the models latent geometry that may extend to other binder target-datasets where identity leakage confounds evaluation.

bioinformatics↗